Synovial Immunophenotype and Anti-Citrullinated Protein Antibodies in RA patients: Relationship to treatment response and radiological prognosis.

Orr C, Najm A, Biniecka M, McGarry T, Ng CT, Young F, Fearon U, Veale DJ. Arthritis Rheumatol. 2017 Jul 21.

Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells.

Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, Lin NY, Dietel K, Bozec A, Herrmann M, Kaplan MH, Weigmann B, Zaiss MM, Fearon U, Veale DJ, Cañete JD, Distler O, Rivellese F, Pitzalis C, Neurath MF, McKenzie ANJ, Wirtz S, Schett G, Distler JHW, Ramming A. Nat Med. 2017 Aug;23(8):938-944

Synovial tissue research: a state-of-the-art review.

Orr C, Sousa E, Boyle DL, Buch MH, Buckley CD, Cañete JD, Catrina AI, Choy EHS, Emery P, Fearon U, Filer A, Gerlag D, Humby F, Isaacs JD, Just SA, Lauwerys BR, Le Goff B, Manzo A, McGarry T, McInnes IB, Najm A, Pitzalis C, Pratt A, Smith M, Tak PP, Thurlings R, Fonseca JE, Veale DJ. Nat Rev Rheumatol. 2017 Aug;13(8):463-475.

Response to: ustekinumab inhibits Th1 and Th17 polarisation in a giant-cell arteritis patient by Samson et al.

Conway R, Fearon U, Molloy ES. Ann Rheum Dis. 2017 May 25. pii: annrheumdis-2017-211669

Cellular and molecular perspectives in rheumatoid arthritis.

Veale DJ, Orr C, Fearon U. Semin Immunopathol. 2017 Jun;39(4):343-354.

CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression.

Guo Y, Walsh AM, Fearon U, Smith MD, Wechalekar MD, Yin X, Cole S, Orr C, McGarry T, Canavan M, Kelly S, Lin TA, Liu X, Proudman SM, Veale DJ, Pitzalis C, Nagpal S. J Immunol. 2017 Jun 1;198(11):4490-4501

Brief Report: Genetic Variation of the α1 -Antitrypsin Gene Is Associated With Increased Autoantibody Production in Rheumatoid Arthritis.

McCarthy C, Orr C, Fee LT, Carroll TP, Dunlea DM, Hunt DJL, Dunne E, O’Connell P, McCarthy G, Kenny D, Fearon U, Veale DJ, Reeves EP, McElvaney NG. Arthritis Rheumatol. 2017 Aug;69(8):1576-1579.

The role of metabolism in the pathogenesis of osteoarthritis.

Mobasheri A, Rayman MP, Gualillo O, Sellam J, van der Kraan P, Fearon U. Nat Rev Rheumatol. 2017

Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in Rheumatoid Arthritis.

McGarry T, Biniecka M, Gao W, Cluxton D, Canavan M, Wade S, Wade S, Gallagher L, Orr C, Veale DJ, Fearon U. Sci Rep. 2017 Feb 22;7:43165.

Response to: ‘Regulatory role of the JAK STAT kinase signalling system on the IL-23/IL-17 cytokine axis in psoriatic arthritis’ by Raychaudhuri et al.

McGarry T, Gao W, Veale DJ, Fearon U. Ann Rheum Dis. 2017 Feb 8. pii: annrheumdis-2017-211081

Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells.

Basdeo SA, Cluxton D, Sulaimani J, Moran B, Canavan M, Orr C, Veale DJ, Fearon U, Fletcher JM. J Immunol. 2017 Mar 15;198(6):2249-2259.



Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.

Fearon U, Canavan M, Biniecka M, Veale DJ. Nat Rev Rheumatol. 2016 Jul;12(7):385-97

Ustekinumab for the treatment of refractory giant cell arteritis.

Conway R, O’Neill L, O’Flynn E, Gallagher P, McCarthy GM, Murphy CC, Veale DJ, Fearon U, Molloy ES. Ann Rheum Dis. 2016 Aug;75(8):1578-9.



What makes psoriatic and rheumatoid arthritis so different?

Veale DJ, Fearon U. RMD Open. 2015 Apr 28;1(1):e000025